What is the J code for Synvisc?
What is the J code for Synvisc?
J7325
SYNVISC Reimbursement Billing Codes
| Synvisc-One and SYNVISC Billing Codes | |
|---|---|
| 58468-0090-03 | Synvisc-One |
| HCPCS | |
| J7325 | For Synvisc-One and SYNVISC, per 1mg |
| Synvisc-One | 48 in Units field of CMS-1500 Claim form or electronic equivalent |
What is the J code for famotidine?
Famotidine Injection (Pepcid®) HCPCS Code J3490: Billing Guidelines.
What is the J code for Zilretta?
Triamcinolone Acetonide Extended-Release Injectable Suspension, for Intra-Articular Use (Zilretta) HCPCS Code J3490: Billing Guidelines.
What is the J code for chemotherapy drug?
The HCPCS Level II establishes “Chemotherapy Drugs” as J9000-J9999.
What is a temporary J code?
Each infused drug, or non-oral, non-self-administered drug that may be used in the inpatient, outpatient hospital, doctor’s office, or infusion center is assigned a temporary and then permanent J code when it is released into the market in order to be able to bill for it with medical claims.
What is monovisc ®?
MONOVISC ® is a non-avian sourced viscosupplement that provides early and durable pain relief in a single high concentration injection that is conveniently packaged in a 4 mL volume for ease of use by physicians and minimum injection discomfort for patients. 1
What is monovisc® (hyaluronan)?
The drug Monovisc®, a brand name for hyaluronan, treats knee pain in patients with osteoarthritis. One unit of this code represents one dose of hyaluronan to be administered through the intraarticular route, which is an injection into a joint, the point of union of two musculoskeletal structures, such as two bones.
What are the J-codes available for HCPCS?
HCPCS codes (J-codes) can be administered through a member’s medical or pharmacy benefit. A few important notes: J9299 Opdivo (nivolumab) J0129 Orencia (abatacept) J7324 Orthovisc (hyaluronan or derivative) J3490 Otrexup (methotrexate) J3490/C9074/J0224 Oxlumo (lumasiran)
How is Synvisc-One/hyalan administered?
* Synvisc-one/Hyalan, Gel-One® and Monovisc™ are administered as a single intra-articular injection per course of treatment. The other brands are administered as an intra-articular injection over multiple weeks per course of treatment.
